期刊文献+

血液透析患者血清脂联素瘦素与脂代谢异常的相关性研究 被引量:1

暂未订购
导出
摘要 目的探讨血液透析患者血清脂联素、瘦素与脂代谢异常的相关性。方法2010年1月至2012年1月,分别检测110例血液透析患者和60例健康体检者血清中总胆固醇、甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、脂联素和瘦素水平变化。结果血液透析组血清甘油三酯、脂联素和瘦素水平明显高于对照组(P〈0.05),两组总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇水平比较,差异无统计学意义(P〉0.05)。血液透析患者血清脂联素与甘油三酯、瘦素呈显著正相关(P〈0.05),瘦素与甘油三酯、脂联素呈显著正相关(P〈0.05)。结论血液透析患者血清脂联素、瘦素明显升高,与脂代谢紊乱密切相关,对预测和预防心血管并发症的发生具有重要的临床意义。 Objective To discuss the correlation between serum adiponectin, leptin and abnormal lipid metabolism in hemodialysis patients. Method From January 2010 to January 2012, the levels ofadiponectin, leptin, total cholesterol, trigly-ceride, high density, lipoprotein cholesterol, low density lipoprotein cholesterol were detected in 110 cases with hemodialysis patients and 60 cases with healthy controls. Results The levels of adiponectin, leptin and trigly-ceride in hemodialysis group were significantly higher than those in control group ( P〈0.05 ) , while no significant differences in total cholesterol, high density, lipoprotein cholesterol, low density lipoprotein cholesterol between two groups (P〉0.05) . In hemodialysis patients, the levels of adiponectin were significantly positive correlated with trigly-ceride and leptin ( P〈0.05 ) , and the levels of leptin were significantly positive correlated with trigly-ceride and adiponectin ( -P〈O.05 ) . Conclusion Serum adiponectin and leptin are significantly increased in hemodialysis patients, and are correlated with abnormal lipid metabolism, which has significance for predicting and preventing cardiovascular complications.
出处 《浙江临床医学》 2013年第1期27-29,共3页 Zhejiang Clinical Medical Journal
关键词 脂联素 瘦素 脂代谢 血液透析 Adiponectin Leptin Lipid metabolism Hemodialysis
  • 相关文献

参考文献10

二级参考文献57

  • 1刘秀荣.血液透析并发症的观察与处理[J].齐鲁护理杂志,2005,11(2):141-142. 被引量:5
  • 2潘华,余叶蓉.脂肪因子对血管内皮细胞功能的影响[J].现代临床医学,2007,33(1):72-74. 被引量:5
  • 3刘宏宝,陈威,王汉民,张鹏,许国双,白淑蓉,孙世仁,刘晓渭.高通量血液透析在慢性肾衰竭患者治疗中的综合评价[J].中国血液净化,2007,6(5):253-256. 被引量:28
  • 4NKF-DOQI. NKF-DOQI clinical practice guideline for hemodialysis adequacy[J]. Am J Kidney Dis, 1997, 30(Suppl):15-66.
  • 5Matsuzawa Y, Funahashi T, Nakamura T. Molecularmechanism of metabolic syndrome X:contribution of adipocytokines, adipocyte-derived bioactive substances[J].Ann N Y Acad Sci, 1999,892:146-154.
  • 6Mamyoshi H, Kojima S, Funahashi T, et al. Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina[J]. Thromb Haemost, 2004,91:1026-1030
  • 7Zoccali c, Mallomaci F, Tripeii G, et al. Adiponectin, meta bolic risk factirs, and cardiovascular events among patients with end-stage renal disease [J].J Am Soc Nephrol, 2002,13:134-141.
  • 8Koshimura J, Fujita H, Narita T, et al. Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy[J]. Biochem Biophys Res Commun, 2004, 316:165-169.
  • 9Zoccali C, Mallomaci F, Panuccio V, et al. Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors[J].Kidney Int, (Suppl),2003, S98-102
  • 10Chudek J, Adamczak M, Karkoszka H, et al. Plasma adiponectin concentration before and after successful kidney transplantation[J].Transplant Proc, 2003,35:2186-2189

共引文献37

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部